Literature DB >> 21148309

microRNA-92a promotes lymph node metastasis of human esophageal squamous cell carcinoma via E-cadherin.

Zhao-li Chen1, Xiao-hong Zhao, Ji-wen Wang, Bao-zhong Li, Zhen Wang, Jian Sun, Feng-wei Tan, Da-peng Ding, Xiao-hui Xu, Fang Zhou, Xiao-gang Tan, Jie Hang, Su-sheng Shi, Xiao-li Feng, Jie He.   

Abstract

microRNAs (miRNAs) regulate gene expression at the post-transcriptional level and play important roles in tumor initiation and progression. Recently, we examined the global miRNA expression profile of esophageal squamous cell carcinoma (ESCC) and demonstrated that miR-92a was highly expressed in tumor tissues. In this study, we found that the up-regulation of miR-92a was significantly correlated with the status of lymph node metastasis and TNM stage in 107 ESCC patients. Moreover, the up-regulation of miR-92a was associated with poor survival of ESCC patients and might be used as an independent prognostic factor. Next, we investigated the role and mechanism of miR-92a in ESCC cells, and found that miR-92a modulated the migration and invasion but not apoptosis and proliferation of ESCC cells in vitro. We further demonstrated that miR-92a directly targeted the CDH1 3'-UTR and repressed the expression of CDH1, a tumor metastasis suppressor. In addition, restoring of miR-92a-resistant CDH1 expression in miR-92a-overexpression cells recovered the pro-metastasis activity of miR-92a. Taken together, we demonstrated that miR-92a promotes ESCC cell migration and invasion at least partially via suppression of CDH1 expression, and patients with up-regulated miR-92a are prone to lymph node metastasis and thus have poor prognosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21148309      PMCID: PMC3060523          DOI: 10.1074/jbc.M110.165654

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  Pin1 expression contributes to lung cancer: Prognosis and carcinogenesis.

Authors:  Xiaogang Tan; Fang Zhou; Junting Wan; Jie Hang; Zhaoli Chen; Baozhong Li; Cuiyan Zhang; Kang Shao; Peng Jiang; Susheng Shi; Xiaoli Feng; Ning Lv; Zhen Wang; Yun Ling; Xiaohong Zhao; Dapeng Ding; Jian Sun; Meihua Xiong; Jie He
Journal:  Cancer Biol Ther       Date:  2010-01-17       Impact factor: 4.742

2.  The microRNA miR-92 increases proliferation of myeloid cells and by targeting p63 modulates the abundance of its isoforms.

Authors:  Isabella Manni; Simona Artuso; Silvia Careccia; Maria Giulia Rizzo; Renato Baserga; Giulia Piaggio; Ada Sacchi
Journal:  FASEB J       Date:  2009-07-16       Impact factor: 5.191

3.  MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival.

Authors:  Ewy A Mathé; Giang Huong Nguyen; Elise D Bowman; Yiqiang Zhao; Anuradha Budhu; Aaron J Schetter; Rosemary Braun; Mark Reimers; Kensuke Kumamoto; Duncan Hughes; Nasser K Altorki; Alan G Casson; Chang-Gong Liu; Xin Wei Wang; Nozomu Yanaihara; Nobutoshi Hagiwara; Andrew J Dannenberg; Masao Miyashita; Carlo M Croce; Curtis C Harris
Journal:  Clin Cancer Res       Date:  2009-09-29       Impact factor: 12.531

4.  miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis.

Authors:  Li Ma; Jennifer Young; Harsha Prabhala; Elizabeth Pan; Pieter Mestdagh; Daniel Muth; Julie Teruya-Feldstein; Ferenc Reinhardt; Tamer T Onder; Scott Valastyan; Frank Westermann; Frank Speleman; Jo Vandesompele; Robert A Weinberg
Journal:  Nat Cell Biol       Date:  2010-02-21       Impact factor: 28.824

5.  Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transition.

Authors:  Ausra Bendoraite; Emily C Knouf; Kavita S Garg; Rachael K Parkin; Evan M Kroh; Kathy C O'Briant; Aviva P Ventura; Andrew K Godwin; Beth Y Karlan; Charles W Drescher; Nicole Urban; Beatrice S Knudsen; Muneesh Tewari
Journal:  Gynecol Oncol       Date:  2009-10-24       Impact factor: 5.482

6.  MicroRNA expression signatures in Barrett's esophagus and esophageal adenocarcinoma.

Authors:  Hushan Yang; Jian Gu; Kenneth K Wang; Wei Zhang; Jinliang Xing; Zhinan Chen; Jaffer A Ajani; Xifeng Wu
Journal:  Clin Cancer Res       Date:  2009-09-08       Impact factor: 12.531

7.  Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells.

Authors:  Asish K Ghosh; Tait D Shanafelt; Amelia Cimmino; Cristian Taccioli; Stefano Volinia; Chang-gong Liu; George A Calin; Carlo M Croce; Denise A Chan; Amato J Giaccia; Charla Secreto; Linda E Wellik; Yean K Lee; Debabrata Mukhopadhyay; Neil E Kay
Journal:  Blood       Date:  2009-03-31       Impact factor: 22.113

8.  MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice.

Authors:  Angelika Bonauer; Guillaume Carmona; Masayoshi Iwasaki; Marina Mione; Masamichi Koyanagi; Ariane Fischer; Jana Burchfield; Henrik Fox; Carmen Doebele; Kisho Ohtani; Emmanouil Chavakis; Michael Potente; Marc Tjwa; Carmen Urbich; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Science       Date:  2009-05-21       Impact factor: 47.728

9.  MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression.

Authors:  B Diosdado; M A van de Wiel; J S Terhaar Sive Droste; S Mongera; C Postma; W J H J Meijerink; B Carvalho; G A Meijer
Journal:  Br J Cancer       Date:  2009-08-18       Impact factor: 7.640

10.  MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma.

Authors:  H-C Chen; G-H Chen; Y-H Chen; W-L Liao; C-Y Liu; K-P Chang; Y-S Chang; S-J Chen
Journal:  Br J Cancer       Date:  2009-03-24       Impact factor: 7.640

View more
  66 in total

1.  Overexpression of miR-92a correlates with tumor metastasis and poor prognosis in patients with colorectal cancer.

Authors:  Tong Zhou; Guangjun Zhang; Zuoliang Liu; Shusen Xia; Hongpeng Tian
Journal:  Int J Colorectal Dis       Date:  2012-07-07       Impact factor: 2.571

Review 2.  The role of microRNA in esophageal squamous cell carcinoma.

Authors:  Kazuto Harada; Yoshifumi Baba; Takatsugu Ishimoto; Hironobu Shigaki; Keisuke Kosumi; Naoya Yoshida; Masayuki Watanabe; Hideo Baba
Journal:  J Gastroenterol       Date:  2016-01-21       Impact factor: 7.527

3.  MicroRNA-92a functions as an oncogene in colorectal cancer by targeting PTEN.

Authors:  Guangjun Zhang; He Zhou; Huaxu Xiao; Zuoliang Liu; Hongpeng Tian; Tong Zhou
Journal:  Dig Dis Sci       Date:  2013-09-12       Impact factor: 3.199

4.  Downregulation of YAP inhibits proliferation and induces apoptosis in Eca-109 cells.

Authors:  Mu Cui; Zhen Li
Journal:  Exp Ther Med       Date:  2017-11-10       Impact factor: 2.447

5.  MicroRNA-330-3p functions as an oncogene in human esophageal cancer by targeting programmed cell death 4.

Authors:  Hui Meng; Kai Wang; Xuedan Chen; Xingying Guan; Liwen Hu; Gang Xiong; Juan Li; Yun Bai
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

6.  MicroRNA-92 promotes invasion and chemoresistance by targeting GSK3β and activating Wnt signaling in bladder cancer cells.

Authors:  Haifeng Wang; Changxing Ke; Xingyong Ma; Qinghua Zhao; Mingying Yang; Wei Zhang; Jiansong Wang
Journal:  Tumour Biol       Date:  2016-11-09

Review 7.  The role of microRNAs in cancers of the upper gastrointestinal tract.

Authors:  Shumei Song; Jaffer A Ajani
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-11-20       Impact factor: 46.802

8.  Locked nucleic acid inhibits miR-92a-3p in human colorectal cancer, induces apoptosis and inhibits cell proliferation.

Authors:  S Ahmadi; M Sharifi; R Salehi
Journal:  Cancer Gene Ther       Date:  2016-05-20       Impact factor: 5.987

9.  Effects and interactions of MiR-577 and TSGA10 in regulating esophageal squamous cell carcinoma.

Authors:  Xiang Yuan; Jiangtu He; Fenyong Sun; Jiang Gu
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15

Review 10.  miRNAs regulate expression and function of extracellular matrix molecules.

Authors:  Zina Jeyapalan Rutnam; Thomas N Wight; Burton B Yang
Journal:  Matrix Biol       Date:  2012-11-15       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.